News
Hoskinson proposes converting 140M ADA to stablecoins to boost Cardano’s DeFi liquidity. Critics warn the plan could trigger ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...
Cardano (ADA) founder announced the launch of Cardinal, a DeFi protocol built to enable Bitcoin holders to access services like staking and lending.
16h
MT Newswires on MSNTop Cryptocurrencies Fall; Bitcoin Holds Near $107,000 LevelMajor digital assets fell late Thursday afternoon, with Bitcoin (BTC-USD) holding near the $107,000 level. The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, shed 1.1% ...
1d
Week99er on MSNCardano’s NASDAQ Crypto Index Inclusion Triggers Institutional Buzz—Qubetics and Toncoin Builds for Breakout in Top Rated Crypto RankingsDiscover why Qubetics, Cardano, and Toncoin are dominating top rated crypto trends. Explore updates, presale figures, and ...
Cardano (ADA) price hovers above key resistance near $0.695 as ETF buzz and new rewards boost investor sentiment.
The $0.70 level is a key psychological support zone for ADA's price stability, CoinDesk Research's technical analysis shows.
A decade ago, most people didn't know what Bitcoin (BTC) was, let alone include it as part of their investment plan, and many leaders from financial firms were quick to call cryptocurrency a scam.
Cardano has launched the first Bitcoin DeFi protocol, Cardinal, triggering a sharp rise in the price and trading volume of ...
Cardano (ADA) joins the Nasdaq Crypto Index, gaining more exposure to Wall Street and showing growing support from ...
Explore the XRP flag pattern indicating a bullish trend with a potential 50% upside. Understand the factors driving momentum.
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced an upcoming podium presentation highlighting ongoing clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results